| Active Grants |
Project Period |
| Genetics of Asthma and Bronchial Hyper Responsiveness |
7/94 - 5/08 |
| Genotype-Phenotype Interactions in Severe Asthma |
9/01 - 6/11 |
| Spontaneous Regression of Late-stage Tumors in Mice |
7/02 - 6/07 |
| Type 1 Diabetes Genetics Consortium Data Coordinating Center |
9/02 - 8/07 |
| NIA Older Americans Independence Centers |
9/02 - 8/07 |
| Polymorphisms of INS/IGF Signal Pathways in Female Cancer |
7/03 - 6/07 |
| G-Protein-coupled Receptor Signaling in Airway Smooth Muscle |
9/03 - 7/07 |
| Mapping Prostate Cancer Susceptibility Genes at 8p22-2 |
9/03 - 8/08 |
| Asthma Clinical Research Network |
9/03 - 7/08 |
| Regulation of Cysteinyl Leukotriene Type 1 rRceptor |
3/04 - 2/08 |
| Familial CaP Susceptibility Genes |
7/04 -12/07 |
| Interaction of PTEN and CDKN1B in PCa susceptibility |
9/04 - 8/09 |
| Genetic Studies in Difficult to Treat Asthma: TENOR |
9/04 - 6/08 |
| Re-engineering the Clinical Research Enterprise: feasibility of integrating and expanding clinical networks |
10/04 – 9/07 |
| Clinical Centers for a Clinical Research Network for the Treatment of Acute Lung Injury and the Adult Respiratory Distress Syndrome (ARDS)" |
2005-2012 |
| Severe Asthma and the Glucocorticoid Receptor Complex |
4/05 – 3/07 |
| Beta-adrenergic receptor agonism and T Cells |
7/05 – 6/07 |
| Identification of Diabetes Genes on Human Chromosome 20 |
7/05 – 6/10 |
| Pharmacogenetics of Asthma Treatment |
7/05 – 6/10 |
| Models & Technologies for Defining Phenotype |
9/05 – 8/07 |
| Clinical Centers for the Clinical Network for the Treatment of the Adult Respiratory Distress Syndrome (ARDS) |
9/05 – 8/12 |
| Acute Inflammatory Mediators On Duration Of Functional Limitations In Elderly Patients With Acute Respiratory Failure |
2006-2007 |
| General Clinical Research Center (GCRC) |
3/06 – 2/11 |
| The Center for Botanical Lipids, Core A |
4/05 – 3/10 |
| Mitochondrial and Oxidative Stress in Type 1 Diabetes |
4/06 – 3/08 |
| Phospholipase-Mediated Surfactant Injury Contributes To The Pathogenesis, Progression And Clinical Course Of ALI/ARDS |
4/07-2012 |
| Global Genetic And Epigenetic Approaches To Progression Of Pca |
4/08-3/13 |
Interaction Effect Of 8q24 Germline And Somatic DNA Changes On Aggressive Prostate Cancer
|
7/08-6/11 |
| Completed |
|
| Education in Patient Oriented Research |
6/99 - 5/05 |
| Iron Overload and Hereditary Hemochromatosis |
2/00 - 1/05 |
| Identification of an Asthma Susceptibility Gene on 3P |
9/00 - 8/06 |
| sPLA2 and Surfactant in Asthma |
9/00 - 7/04 |
| Identification of Susceptibility Genes for NIDDM |
7/01 - 6/05 |
| Gene Polymorphisms and Prevention of Disability |
8/01 – 7/04 |
| The Pharmacogenomics of Methotrexate |
9/01 - 6/06 |
| Molecular Mechanisms Regulating Synthetic Functions of Human Airway Smooth Muscle |
10/01-10/06 |
| Regulation of G-Protein-coupled Receptors in air Myocytes |
3/02 - 2/05 |
| Molecular Genetics of Colon Cancer in Blacks and Whites |
11/02 - 2/06 |
| Vitamin Intervention for Stroke Prevention |
8/03 - 7/05 |
| Human Airway Smooth Muscle Growth Regulation by G-Protein-coupled Receptors |
9/03 - 5/05 |
| Airway Smooth Muscle Modulated Inflammation in Asthma- (Project) 1 |
9/03 - 8/06 |
| Mesenchymal Cell Fibrogenesis Triggered by Epithelial Cells in Asthma (Project 4) |
9/03 - 8/06 |
| Airway Smooth Muscle Modulated Inflammation in Asthma - Human Studies Cor e |
B9/03 - 8/06 |
| Phenotypic and Genotypic Determinants to Identify Patients at High Risk for Mesothelioma |
1/04 - 12/05 |
| Utility of SNP Genotyping Using Pooled DNA Samples in Association Studies |
9/04 - 8/06 |
| SCGF in Kidney Cancer |
3/04 - 3/05 |
| Estrogen Receptor Variants, HDL, and Atherosclerosis |
3/04 - 2/06 |
| Cystic Fibrosis Foundation |
4/04 - 3/06 |
| Interactive effects of steroids and PKA-activating agents in Regulating Cytokine effects on airway smooth muscle growth |
1/06–12/06 |
| Interactive effects of beta-agonists and steroids on T cell functions |
1/06–12/06 |